Given somatic CN deletion‐induced NUDT15 deficiency can sensitize cancer cells to 6MP, we hypothesized that tumors with somatic loss‐of‐function mutations of NUDT15 could also be treated with 6MP. This evidence concerns the gene NUDT15 and cancer.